Association between tumor necrosis factor polymorphisms and rheumatoid arthritis as well as systemic lupus erythematosus: A meta-analysis

Abstract

Tumor necrosis factor-alpha (TNF-a) plays an important role in autoimmune diseases. Previous studies have investigated the association of TNF-a-238G/A (rs361525) and-308G/A (rs1800629) polymorphisms with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, no agreed conclusion had been made. Therefore, this meta-analysis was conducted to assess the associations of TNF-a-238G/A and-308G/A polymorphisms with RA and SLE risk. A systematic search was conducted in commonly used databases. Meta-analysis was performed by STATA12.0. A total of 43 studies were included. In the overall population, the TNF-a-238A allele was observed to be a protective factor for RA (A vs G: OR=0.75, 95%CI=0.57– 0.99, P=0.040) and the TNF-a-308A allele was found to be a risk factor for SLE (A vs G: OR=1.78, 95%CI=1.45–2.19, Po0.001). However, no evidence of association was found between TNF-a-238 G/A polymorphism and SLE nor between-308G/A and RA. In the subgroup analysis, TNF-a-308A allele played a pathogenic role for RA in Latin Americans (A vs G: OR=1.46, 95%CI=1.15–1.84, P=0.002) and for SLE in Latin Americans (A vs G: OR=2.12, 95%CI=1.32–3.41, P=0.002) and Europeans (A vs G: OR=2.03, 95%CI=1.56–2.63, Po0.001), while it played a protective role for RA in Asians (A vs G: OR=0.54, 95%CI=0.32–0.90, P=0.017). No significant association was found between TNF-a-308G/A and SLE susceptibility in Africans and Asians. This meta-analysis demonstrated that TNF-a-238A was associated with decreased risk of RA rather than SLE, while-308G/A polymorphism was associated with SLE rather than RA. Stratification analysis indicated that different ethnicities would have different risk alleles.